Skepticism surrounds autism drug given ‘fast track’ for approval
In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.
In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.
More than half of people on the spectrum have four to five other conditions. Which conditions, and how and when they appear, varies from one autistic person to the next.
Mouse-model researcher Nicola Grissom snacks on chocolate-covered espresso beans and pops bubble wrap to stay focused.
Private equity firms have injected hundreds of millions of dollars into autism therapy companies — and researchers are hopeful this will widen autistic people’s access to care.
Teenagers in the general population who have trouble with social communication are at double the risk of purposefully harming themselves with suicidal intentions than their peers.
Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.
The California-based company’s phone application for autism diagnosis is not as far along as initial reports suggested.
From an app to diagnose autism to a crowdsourced project to map its prevalence, Dennis Wall is brimming with ambitious ideas. But his execution of these ideas leaves something to be desired, his critics say.
Encounters between law enforcement and people with autism often go wrong, but some police departments are beginning to train their officers.
Boys with autism have smaller heads, are shorter and weigh less at birth than typical children do — but all that changes by age 3.